fbpx

New target for AMD treatment

Researchers have identified a new genetic target for AMD treatment.

One of the genes associated with the risk of AMD is the complement factor H (CFH) gene. It codes the factor H (FH) protein, which protects our eyes from attacks from our own immune system.

The researchers discovered that in the back of the eye, it is not the factor H protein that acts as a protector, but rather the factor “H-like 1” (FHL-1) protein. The protein’s reduced size (about a third of factor H) allows it to get to the structures at the back of the eye, whereas FH cannot.

 

An insufficient amount of FHL-1 in the back of the eye leaves the eyes vulnerable to inflammation and can lead to vision loss.

 

For further information: http://www.jimmunol.org/content/early/2014/10/10/jimmunol.1401613.abstract

Featured Posts

Trinity Capital Provides $45 Million Growth Capital To Neurolens

Trinity Capital Inc., a leading provider of diversified financial solutions to growth-stage companies, announced the commitment of $45 million in growth capital to Neurolens.

Learn More
OptikConED Year end special

Year-End Continuing Education Special: For Opticians and Optometric Assistants

From now until December 31, OptikConED.com offers year-end CE specials starting at $8.95 per course.

Read more

EssilorLuxottica and Moncler Announce Exclusive Licensing Agreement

EssilorLuxottica and Moncler have announced the signing of an exclusive licensing agreement that includes the design, production, and global distribution of Moncler eyewear.

Read more

OSI National Summit 2023: A Milestone Gathering Redefining the Future of Independent Optometry

Taking place at Toronto’s Westin Harbour Castle from November 17 to 19, the 2023 OSI National Summit brought together optometrists, opticians, optometric assistants, managers, and staff.

Read more

Diversity and Inclusion in Eye Care

Canada is an intricate textured tapestry of different cultures. Each patient is unique and presents with different preferences and lifestyle choices.

Read more

Trinity Capital Provides $45 Million Growth Capital To Neurolens

Trinity Capital Inc., a leading provider of diversified financial solutions to growth-stage companies, announced the commitment of $45 million in growth capital to Neurolens.

Learn More
OptikConED Year end special

Year-End Continuing Education Special: For Opticians and Optometric Assistants

From now until December 31, OptikConED.com offers year-end CE specials starting at $8.95 per course.

Read More

EssilorLuxottica and Moncler Announce Exclusive Licensing Agreement

EssilorLuxottica and Moncler have announced the signing of an exclusive licensing agreement that includes the design, production, and global distribution of Moncler eyewear.

Read More

OSI National Summit 2023: A Milestone Gathering Redefining the Future of Independent Optometry

Taking place at Toronto’s Westin Harbour Castle from November 17 to 19, the 2023 OSI National Summit brought together optometrists, opticians, optometric assistants, managers, and staff.

Read More

Diversity and Inclusion in Eye Care

Canada is an intricate textured tapestry of different cultures. Each patient is unique and presents with different preferences and lifestyle choices.

Read More

Trinity Capital Provides $45 Million Growth Capital To Neurolens

Trinity Capital Inc., a leading provider of diversified financial solutions to growth-stage companies, announced the commitment of $45 million in growth capital to Neurolens.

Learn More
OptikConED Year end special

Year-End Continuing Education Special: For Opticians and Optometric Assistants

From now until December 31, OptikConED.com offers year-end CE specials starting at $8.95 per course.

Read more

EssilorLuxottica and Moncler Announce Exclusive Licensing Agreement

EssilorLuxottica and Moncler have announced the signing of an exclusive licensing agreement that includes the design, production, and global distribution of Moncler eyewear.

Read more

OSI National Summit 2023: A Milestone Gathering Redefining the Future of Independent Optometry

Taking place at Toronto’s Westin Harbour Castle from November 17 to 19, the 2023 OSI National Summit brought together optometrists, opticians, optometric assistants, managers, and staff.

Read more

Diversity and Inclusion in Eye Care

Canada is an intricate textured tapestry of different cultures. Each patient is unique and presents with different preferences and lifestyle choices.

Read more

Trinity Capital Provides $45 Million Growth Capital To Neurolens

Trinity Capital Inc., a leading provider of diversified financial solutions to growth-stage companies, announced the commitment of $45 million in growth capital to Neurolens.

Learn More
OptikConED Year end special

Year-End Continuing Education Special: For Opticians and Optometric Assistants

From now until December 31, OptikConED.com offers year-end CE specials starting at $8.95 per course.

Read more

EssilorLuxottica and Moncler Announce Exclusive Licensing Agreement

EssilorLuxottica and Moncler have announced the signing of an exclusive licensing agreement that includes the design, production, and global distribution of Moncler eyewear.

Read more

OSI National Summit 2023: A Milestone Gathering Redefining the Future of Independent Optometry

Taking place at Toronto’s Westin Harbour Castle from November 17 to 19, the 2023 OSI National Summit brought together optometrists, opticians, optometric assistants, managers, and staff.

Read more

Diversity and Inclusion in Eye Care

Canada is an intricate textured tapestry of different cultures. Each patient is unique and presents with different preferences and lifestyle choices.

Read more